We are passionate about delivering transformational, science-led innovation that is distinctly accessible for all. Alzheimer’s, Parksinon’s, COVID-19 and other diseases don’t discriminate based on where you live or how much you make, and we believe medicine shouldn’t either.
Our team is comprised of leaders in neurobiology, infectious disease, drug development and disruptive ideas.
Mei Mei Hu, J.D.
Chief Executive Officer
Lou Reese
Co-Founder and Executive Chairman of the Board
Ulo Palm, MD, Ph.D.
Chief Medical Officer
René Paula Molina
General Counsel and Secretary
Jason Pesile
SVP Finance & Accounting
Jon Harrison
Chief Government Officer
Mark Joinnides
Chief of Staff
Amy Fix
Chief Regulatory Officer
Ben Matone
VP Investor Relations
Jean-Cosme Dodart, Ph.D
SVP Preclinical R&D
Dwayne Soisson
VP Operations
Dario Mirski, MD
SVP Neuro / Chronic Diseases
Farshad Guirakhoo, Ph.D.
Senior Scientific Advisor
Mei Mei Hu, J.D.
Chief Executive Officer
Lou Reese
Co-Founder and Executive Chairman of the Board
Peter Powchik
Director
James Chui
Director
Gregory R. Blatt
Director
Peter H. Diamandis, MD
Director
George Hornig
Director
Thomas P. Monath, M.D.
Crozet BioPharma
Donna Ambrosino, M.D.
WHO, CEPI, ClearSite Antibodies
Wayne Koff, PhD
NIH, Human Vaccines Project
George Siber, M.D.
Johns Hopkins, Wyeth Vaccines (now Pfizer), Affinivax
Brad Boeve, M.D
Mayo Clinic
Nick Fox, M.D
Neurology, UCL
Richard Mohs, Ph.D
Global Alzheimer’s Platform
Eric Reiman M.D
Banner Research
Jeffrey Cummings M.D, ScD.
Cleveland Clinic
Barney Graham M.D, Ph.D
Vaccine Research Center, NIAID
Peter A. Patriarca, M.D.
CDC, FDA, Immuno-Vax
Stanley A. Plotkin, M.D.
Johns Hopkins, Vaxconsult
Sharon Lewin, A.O., FRACP., Ph.D., FAHMS
NHMC, Peter Doherty Institute